Gene Therapies
Article
The importance of utilization management within the medical benefit
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read More
Article
What to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read MoreVideo
Biosimilar Approval and Adoption Challenges
June 10, 2022
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Article
Uncovering behind-the-scenes challenges in bringing gene therapies to market
June 07, 2022
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Article
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
April 20, 2022
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed.
This topic was the focus of a breakout...
Article
How to have a data-driven discussion on gene and cellular therapies
October 28, 2021
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.